APA aipamena

Henry, R. R., Rosenstock, J., Logan, D. K., Alessi, T. R., Luskey, K., & Baron, M. A. (2013). Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes. American Diabetes Association.

Chicago Style aipamena

Henry, Robert R., Julio Rosenstock, Douglas K. Logan, Thomas R. Alessi, Kenneth Luskey, and Michelle A. Baron. Randomized Trial of Continuous Subcutaneous Delivery of Exenatide By ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes. American Diabetes Association, 2013.

MLA aipamena

Henry, Robert R., et al. Randomized Trial of Continuous Subcutaneous Delivery of Exenatide By ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes. American Diabetes Association, 2013.